2021 Multidisciplinary Thoracic Cancers Symposium

December 2, 2021 to December 4, 2021

The 2021 Multidisciplinary Thoracic Cancers Symposium is a two-and-a-half day meeting featuring interactive case discussions; educational sessions on multidisciplinary therapies, new targeted therapies, immunotherapy, treatment and screening guidelines, supportive care; and oral abstract sessions highlighting the most current, evidence-based practices. The goal of this meeting is to provide participants with updates on current clinical and translational initiatives in thoracic malignancies, including targeted therapy, immunotherapy, advanced radiation techniques, surgical methodologies, and pathological advancements in molecular categorization that are relevant to daily clinical practice. Additionally, attendees will be updated on the appropriate integration of these advancements in their daily practice, including indication, patient selection, combinations of different therapeutic modalities, prevention, and management of common toxicities in the context of potentially improved clinical outcomes. This educational activity will focus on several of the most complex and controversial topics in the multidisciplinary management of patients with thoracic cancers to optimize incorporation of recent advances into daily practice.

Target Audience

This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists and pulmonologists.

Learning Objectives

Upon completion of this live activity, participants should be able to:

  • Integrate locally ablative treatment modalities for appropriate patients with oligometastatic lung cancer.
  • Identify the potential advantages of proton-beam radiation therapy for thoracic malignancies.
  • Implement proper monitoring and intervention strategies for immune-related toxicities.
  • Explain the benefit of CT screening for lung cancer.
  • Discuss the relevance of molecular diagnostic testing in the management of patients with thoracic malignancies.
  • Explain the role of multidisciplinary care for early-stage/locally advanced non-small cell lung cancer.

 

Course summary
Available credit: 
  • 16.75 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 16.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 16.75 Certificate of Attendance
    This activity was designated for 16.75 AMA PRA Category 1 Credit™.
  • 17.00 CAMPEP
    This activity has been approved for 17.00 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
Course opens: 
11/15/2021
Course expires: 
12/04/2024
Event starts: 
12/02/2021 - 6:00am
Event ends: 
12/04/2021 - 1:00pm
Cost:
$0.00
Rating: 
0

Physicians
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ASTRO designates this live activity for a maximum of 17 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants who complete the evaluation within 30 days will have online access to their certificate 45 days post-meeting. Participants can access, print and save their certificate from the My ASTRO page of the ASTRO website. Participants who do not complete their evaluations within 30 days must contact ASTRO's Education Department to receive their certificate.

Physicists
This activity has been approved for a maximum of 16 Medical Physics Continuing Education Credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Program (CAMPEP).

Physicist attendees will receive a confirmation certificate of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting. Your official certificate will be available from CAMPEP.

 

Available Credit

  • 16.75 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 16.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 16.75 Certificate of Attendance
    This activity was designated for 16.75 AMA PRA Category 1 Credit™.
  • 17.00 CAMPEP
    This activity has been approved for 17.00 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).

Price

Cost:
$0.00
Please login or register to take this course.

To be eligible to receive continuing education credit, attendees must complete the online evaluation by Monday, April 15, 2019. Please only evaluate the sessions you attended.

CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants will have online access to their certificate upon completion of the evaluation. Participants can access, print and save their certificate from ASTRO Academy.

Physicist attendees will not receive certificates of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting.